Forced over-expression of EphB4 in non-tumorigenic MCF10A breast cells and in 22Rv1 prostate cancer cells led to transformation of the MCF10A line and increased the metastatic phenotype of the 22Rv1 cells [28]. The gene discussed is EPHB4; the disease is prostate cancer.